Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
33.69
-1.62 (-4.59%)
Feb 21, 2025, 4:00 PM EST - Market closed
Sanara MedTech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Sanara MedTech stock have an average target of 47, with a low estimate of 44 and a high estimate of 50. The average target predicts an increase of 39.51% from the current stock price of 33.69.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 23, 2025.
Analyst Ratings
The average analyst rating for Sanara MedTech stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $44 | Buy | Reiterates | $44 | +30.60% | Jan 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +48.41% | Jan 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +48.41% | Dec 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $44 | Buy | Reiterates | $44 | +30.60% | May 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $49 → $44 | Buy | Maintains | $49 → $44 | +30.60% | Mar 27, 2024 |
Financial Forecast
Revenue This Year
87.91M
from 64.99M
Increased by 35.26%
Revenue Next Year
106.18M
from 87.91M
Increased by 20.79%
EPS This Year
-1.12
from -0.52
EPS Next Year
-0.99
from -1.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 90.6M | 112.6M | 118.2M |
| Avg | 87.9M | 106.2M | 114.9M |
| Low | 84.4M | 99.0M | 110.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 39.4% | 28.0% | 11.3% |
| Avg | 35.3% | 20.8% | 8.2% |
| Low | 29.8% | 12.6% | 3.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.10 | -1.01 | -0.70 |
| Avg | -1.12 | -0.99 | -0.68 |
| Low | -1.13 | -0.96 | -0.66 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.